US FDA Wants Remote Regulatory Assessment Authority For Cosmetics – FY 2023 Budget Justification
After freezing its routine inspection activities at the height of the COVID-19 pandemic, the FDA adapted its oversight approach visibly in the drug and medical devices sectors, including with voluntary remote regulatory assessments. The agency now seeks authority to continue that work on a non-voluntary basis across all FDA-regulated programs.
You may also be interested in...
The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.
Biden administration’s FY2023 budget request for FDA includes $1.23bn for food programs, which include regulation of supplement manufacturing and marketing. The funding, an increase of more than $128,000 from FDA’s current food programs budget, would be split between $419,932 for CFSAN and $800,261 for related field work by ORA.
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.